Emla Patch 25 mg/ 25 mg Patches
PDF Leaflet Revision Date: 02 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Topical anaesthesia of intact skin for minor procedures.
Dosage (summary)
Adults: Apply 1 patch for at least 1 hour; max 5 hours. Children: 1-5 years max 10 patches, 6-11 years max 20 patches.
Onset of Action / Duration
Onset: 1 hour, Duration: decreases after 5 hours
Special Populations
- Paediatric population
- Geriatric population
Pregnancy & Breastfeeding
Use with caution in pregnancy; safe during breastfeeding if not applied to the breast.
Key Drug Interactions
- Methaemoglobin-inducing medicines
- Other local anaesthetics
Contraindications
- Hypersensitivity to local anaesthetics
- Infants <12 months on methaemoglobin-inducing medicines
Common side effects
- Local reactions (paleness, erythema, oedema)
- Methaemoglobinaemia
- Allergic reactions
Counselling Points
- Apply at least 1 hour before procedure
- Do not exceed recommended application time
- Monitor for allergic reactions
Serious warnings
- Risk of methaemoglobinaemia in susceptible patients
- Not for open wounds
- Caution in atopic dermatitis
Important Disclaimer
The Emla Patch 25 mg/ 25 mg Patches professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
